ESMA answers Alternative Performance Measures questions

Posted on April 24, 2020 by Editor

With the Covid-19 fallout making unprecedented modifications to business-as-usual these past few months, the European Securities and Markets Authority (ESMA) has issued updated guidance on the application of Alternative Performance Measures (APM Guidelines) in context of the pandemic.

The new Q&A highlights the main relevant principles of the APM Guidelines, which should be used when disclosing Alternative Performance Measures in management reports, prospectuses and ad-hoc disclosures.

The guidance encourages caution when adjusting APMs or including new APMs in light of Covid-19 effects, and invites issuers to provide narrative information on how the pandemic has impacted operations and performance, and on any measures taken to address that impact.

Read more and find the Q&A here.

Other Posts


Would you like
to learn more?

Join our Newsletter mailing list to
stay plugged in to the latest
information about XBRL around the world.

By clicking submit you agree to the XBRL International privacy policy which can be found at xbrl.org/privacy